Rick Simpson Oil (RSO) e Viti: Na iVola Iwiliwili e OilWell Cannabis

Bula, Vit. Keitou sa wilika oqo mai Suva, Nadi, Lautoka, se e dua na vanua e na veiyasana vinaka ni noda vanua sa lolova ni Pasifika, ko vakavuna e dua na ka: ko vinakata na veivakaduiduitaki dina me baleta na Rick Simpson Oil. O kila vakavinaka na veitarogirugi — na nona tukuna na tamata mucunamata mai Kanada o a vakabauta ni rawa ni vinakata na waiwai ni cannabis ka vakavotuka ni sa bale na iVakavuvuli ni Bula. O kila vakavinaka na veitarogirugi — na nona tukuna na tamata mucunamata mai Kanada o a vakabauta ni rawa ni vinakata na waiwai ni cannabis ka vakavotuka ni sa bale na iVakavuvuli ni Bula. O sega ni kila beka ni ko sa vakayagataka na waiwai ni cannabis? O sa sega ni kila beka ni ko sa vakayagataka na waiwai ni cannabis? O sa sega ni kila beka ni ko sa vakayagataka na waiwai ni cannabis?

Keitou kila. Keitou e OilWell Cannabis, keitou tiko mai kea me solia vei kemuni na ka keitou a vinakata me keitou saumaki mai na gauna ni keitou sa qarava na cakacaka qo: na vuli vakayaga, vakadidike kei na kila dina me baleta na RSO — na ka dina e tiko kina, na ka e tukuna tiko na vakadidike dina, kei na kena vakayagataki ena noda soqosoqo ni Pasifika.

Na ka Dina e Tiko Kina na Rick Simpson Oil?

Me keitou cavuta ena gauna oqo na dina, ni ko vinakata na ka oqo. E sega ni dokita o Rick Simpson. E tamata mucunamata mai Nova Scotia, Kanada, a sucu ena 1949, a dui tataqe ena 1997 ka vakacacani na uluna sa vakayacora me tiko na tinnitus kei na leqa tale eso e uluna. Ni sa bale na iVakavuvuli ni Bula e solia vei koya, sa qai dau vakayagataka na cannabis. Ni sa taroga na nona dokita me vakasama na cannabis e dua na veisau, sa tukuna na dokita “sega” .

Ena 2003, sa tukuna o Simpson ni sa raici na veicuru e ono e na ligana — sa kaci cancer — sa lesu tale ena waiwai ni cannabis vakavotuka ni sa tekivuna ka sa kuvai ena bati e va na siga. E sega ni wili na biopsy me vakadeitaka oqo. E sega ni tiko na iTukutuku ni Bula me vakadeitaka oqo. Ia oqo na nona tukutuku vakaiyalayala sa qai yacora na “Rick Simpson Oil” ka vakayacora na tiki ni vuravura .

**iTuvatuva vakaidina: ** Na tukutuku ni Simpson e tukutuku vakaiyalayala, sega ni vakadidike ni Bula. E sega ni vakadeitaka e dua na iVakavuvuli ni Bula, ia e virikotori vakatabakidua ena vosa ni vuravura me baleta na waiwai ni cannabis vakavotuka.

Ni sa oti na nona tukutuku ena 2003, sa vakayacora o Simpson me tekivuna kei na vakasoliasoli vakadodomo na waiwai vei ira na lewe ni vuravura. Sa tukuna ni sa vukea na tamata e na cancer, cega tawa mudu, suka, vakasakiti, glaucoma, kana, depekana, sega ni moce, kei na ka tale eso . Na nona documentary ena 2005 Run From The Cure sa vakayacora me yaco vakatabakidua, ia sa vakavotukana kei na lawa ni Kanada — na RCMP ra sa vakamuria ena 2005 kei na 2009, na charges, ka sa qai vakacurumi ena Europe .

E na kena iVola Bale, sa vakabauta tiko o Simpson ni rawa ni vakabulai na cancer na waiwai ni cannabis ka ni sa bureitaka mai na iVakavuvuli ni Bula kei na matanitu. Sa qai vakavotukana na nona cakacaka me vaka e dua na veivakacacani . ** Na ka e tukuna tiko dina: ** sa vakadrawataka na kena qiqo na cannabinoids e dua na vakatovolei ni vakadidike ni Bula ni sa sega ni vakadodonu na vuravura. ** Na ka e vakalevulevutaka: ** na nona tukutuku “cure” e vakatubutaki vakalevu cake na vakadidike, ka na vakayagataka na waiwai vakadodomo me vaka na iVakavuvuli ni Bula e vakavotuka na leqa vakalevu .

Na iTuvatuva RSO Talei: Na ka e Vakarautaka o Simpson

Sa tuvana o Simpson e dua na iTuvatuva vakavotui: 60 na gram ni waiwai vakavotuka ena veisiga e tini na drau . Na ka dina e vakarautaka:

• ** Vicauna 1: ** Dose e sa vakatiki ni kena levu ni buke ni were (10-15mg) e veisiga tolu
• ** Vicauna 2-5: ** Vakalevulevutaka na dose e veisiga va, vakarautaka 1 gram (1,000mg) e veisiga ena vicauna 5
• ** Vicauna 5-12: ** Vakavulica 1 gram e veisiga, vakaseqetaka e tolu
• ** Vakavulica: ** Vakalevu ni vakanidina (sublingual se vakasucu), vakadrala na yaloka ni liga
• ** Veivuke: ** Sa tukuna o Simpson ni vakavulica na THC e veisiga 3-4, ia na kena iYalayala e vakavulica ga
• ** Vakavulica: ** Ni sa oti na 60 gram, 1-2 gram e veiveisiga ni bera ni sega

** iTuvatuya vakaidina me vakatavulica oqo: **

• E sega ni vakadidike vakavotui
• Na RSO Talei e sega ni vakavotui vakadidike — e sega ni kila na kena kaukauwa
• Na dose e levu duadua e solia e 600-900mg ni delta-9 THC e veisiga — e sivia vakalevu na ka e vakadidike kina [13][14][15]
• Na leqa dina e veisiga qo: vakavotuka lelevu, rere, loma, tachycardia, hypotension, kei na cannabis use disorder [1][13][15]
• Na lewe ni vutuniyau e rui vakavotui; vakayagataka na waiwai vakadodomo me vaka na iVakavuvuli ni Bula e vakavotuka na leqa tale eso

Na ka Dina e Tiko Kina na RSO Talei: Na iVakadeitaki

Na RSO Talei e tiki ena iTuvatuva, sega ni vakavotui ni veitayagakula:

• ** Vakatawa: ** Dua ga ni high-THC indica strain, sega ni vakavotui
• ** Vakacurumi: ** Naphtha (petroleum-based) se 99% isopropyl alcohol — sega ni kana
• ** iTuvatuva: ** Bucket, solvent wash, filter, rice cooker evaporation, syringe storage
• ** iRa: ** Karakarawa, drokadroka, vakavotuka, sega ni vakavulica solvent-residual smell
• ** Cannabinoids: ** 60-90% delta-9 THC (estimated), fully decarboxylated, sega ni ratio control
• ** Terpenes: ** Vakarusai vakalevu ena solvent + heat process
• ** Vakavotui: ** Sega — e sega ni dua na batch e dua tu
• ** Vakatovolei: ** Sega — sega ni COAs, sega ni contaminant screening
• ** Residual solvent risk: ** Na naphtha e tawa ni tiko na benzene, toluene, other carcinogens

Na vakasevasei e vei na ka e vakadeitaka na RSO kei na ka e ra nanuma na tamata e vakavotukana na rarawa mai Suva ki Lautoka ki Nadi. Na lewe vuqa ni otioti e tukuna “RSO” e sega ni vaka na iYalayala ni Simpson.

Na Vuna e Vakarusa na Formulas OilWell mai na RSO Talei

Keitou sega ni tiko mai me vakadeitaka na waiwai ni Simpson — keitou tiko mai me vakalailaitaka ena vakadidike vou ka vakaotia na nona iYalayala vakayalodina. Na keitou iTuvatuva me vakatavulica na leqa ni RSO Talei:

** iTuvatuva multi-cannabinoid: ** Na RSO Talei e dau rely tiko ga ena dua na strain. Na keitou formulas e vakavulica e vitu na cannabinoid — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, kei na CBC — ni na vakadidike entourage-effect e vakarautaka na kena vinaka mai na cannabinoid diversity, ia e sega ni vakadeitaki vakalevu [20][29].

** Vakavulica terpene: ** Na RSO Talei e sega ni tiko na terpenes. Keitou vakavulica live terpenes e 5% kei na iTuvatuva e vitu: limonene, myrcene, caryophyllene, pinene, linalool, humulene, kei na terpinolene. E dua na terpene e tiko vua na nona vakadidike e tukuni e ra.

** THCa me dua na iVakacurumi: ** Na RSO Talei e fully decarboxylated tiko. Keitou vakavulica THCa e 1,500mg ni na vakadidike THCa e vakarautaka na nona bioactivity vakayayani sega ni psychoactive [12].

** Vakalailai ni delta-9 THC: ** Na RSO Talei e 60-90% delta-9 THC. Na keitou formula e tawa ni 90mg delta-9 THC vakavolivolita, vakaseqetaka e na 16,590mg ni cannabinoids vakavolivolita. Oqo e vakadeitaka na vakadidike vakalevu ni cannabinoids.

** iTuvatuva vou: ** Na Simpson e nanuma ga na oral oil. Keitou solia sublingual oil kei na vape cartridge, ni na kena iYalayala e dua na delivery route e kaya e tiko na pharmacokinetic profile [14].

** Vakavulica vakabula: ** Na RSO Talei e vakayagataka solvent vakacacana. Na keitou vakacurumi e sega ni solvent, vakayagataka MCT oil carrier kei na veitovolei ni veitayagakula.

** iTuvatuva vakadidike: ** Na Simpson e rely tiko ga na anecdote. Keitou rely tiko ga na peer-reviewed literature kei na evidence hierarchies [1]-[29].

Na yaco vakalagi ni OilWell Cannabis: Na tukutuku E Vukei Viti

Na OilWell Cannabis e vakavulici e Colin Valencia mai Houston, Texas. Ia na keitou tukutuku e sega ni sauma mai e dua na boardroom — e sauma mai e dua na koli e yacana Bentley.

E Colin sa tiko vakadeitaki mai McAllen, Texas, e na veiyasana vakaloloma ni U.S.-Mexico border. Sa vakadidiki na cannabis e na veiyasana vakavulici, sa raici ira na wekana sa mate se sa vakacurumia. E rawa ni lako sese, ia sa vakasala na cannabis. E qai mucunamata na software engineer ka vaka vakadidike ni custom development vei Baylor College of Medicine — e dua na iVakavuvuli ni Bula e vakavulici e Amera. Na veisau qo e vakatavulica na vakadidikeda vakaivola kei na vakadidike ni bula.

** Na tukutuku ni Bentley e na vakavulici ni keitou. ** Ni sa vakayali ka sega ni rawa ni tucake na Bentley, ka sa vakasala na vet ni vakamatei, sa tawani Colin. E dua na tamata ni vakavulici sa taroga: “Ko sa tekivu na ka vakacacani ka sega ni raici CBD?” Na taro qo e vakalailaitaka na ka kece.

Sa vakavulica o Colin e dua na CBD golden paste formula vei Bentley. Mai na vakavayali ka sa vakayacora me mate, sa tucake tale na Bentley, sa lako sese kei Colin me kenai lakolako. E sega ni vakayagataka placebo na koli. Oqo e dina. Sa tiko tale na Bentley e vicauna tini, sa mate vakayalodina ena yabaki 20.

Ena vei vicauna tini qo, sa vakavulica o Colin e vei formula vakavotui ni vei leqa:

• ** Neurodegeneration ** → CBG’s neuroprotective properties kei na THCa’s PPARγ agonism
• ** Dementia ** → CBC’s role e na neurogenesis
• ** Glaucoma ** → THC’s CB1 agonism me baleta na intraocular pressure
• ** Arthritis ** → Multi-pathway anti-inflammatory approaches vakayagataka CBD, CBG, THCa, kei na beta-caryophyllene

** Sega ni vakavulica e dua na cannabinoid. ** Na veileqa ni Bentley e vakayacora me vakavulica e multi-cannabinoid synergy. Oqo e vakavulici kina e 7 na cannabinoid e na keitou RSO — sa mai na lomai, sega ni marketing.

Sa kila tale o Colin na pharmaceutical dependence vakaiyalayala. Sa vakatauba vakadua na PTSD kei na benzodiazepine addiction. Sa biuti Xanax vakadodomo vakayagataka na vakadidiki ni cannabinoid sa vakavulica me bula kina na Bentley. Na keitou Peace Gummies formula e vakavulici e na midnight experiments ni sa vakatubu e na benzo withdrawal. Sa vakayagataka vakadua o Colin na vape form me baleta na nona insomnia kei na severe PTSD. Oqo sega ni vakadidike — sa bula koya.

Sa vakavulica keitou e vei formula e ra vakayagataka tiko na dokta me baleta na Crohn’s, IBS, ulcerative colitis, PTSD, benzo addiction, kei na insomnia. Gauna kece sa vakavulici keitou me vakayalodina na cannabis vei ira na tamata kece, ka vaka vei ira na vegans, diabetics, kei ira e tiko vata kei na vei leqa ni bula.

Na ka E Vakavulicala Na Keda RSO: e Rua na iTuvatuva Dina

** 1. Accessibility over gatekeeping. ** Sega ni veidokai ni medical card. E dua ga e veiyabaki 21+ e rawa ni voli. Keitou vakasoliasoli vei ira na tamata kei na veiyasana mai Viti kei na vei vanua kece ni Pasifika e ra legal na iYalayala ni hemp-derived. Sa vakabauta o Rick Simpson ni dauvinakata na iVakavuvuli me vakayalodina; keitou sa tuvana e dua na iTuvatuva vakasoliasoli legal me vakayalodina oqo.

** 2. Patient-controlled potency. ** Na THCa e vakasoliasoli e na nona acidic, sega ni psychoactive. Ko oqo e vakatovolei vakalevu: vakayagataka raw (zero impairment) se decarboxylate kina me delta-9 THC me baleta na full psychoactive potency. Sa vakabauta o Rick Simpson ni dauvinakata na iVakavuvuli me vakayalodina; keitou sa vakavulica e dua na iVakavuvuli me vakayacora oqo ena ligamuni ena vakadidike.

** 3. Open-source formulas. ** Keitou vakapublica na formulas vakatotolo — e vei cannabinoid, e vei milligram, e vei percentage. Keitou sega ni rawa ni vakayagataka na keda products, ko rawa ni kauta na ingredients ka vakavulica e nomuni. Sa solia vakadodomo na nona waiwai o Rick Simpson; keitou sa vakalailaitaka na iYalayala qo me baleta na iTuvatuva vou ni vakacurumi ni tekivu ena vakasoliasoli e dua na iVakavuvuli vakayalodina kei na vakapublica na recipe. E muri ni vei vola qo, keitou vakasoliasoli na formulas e rau vei me baleta na keda sublingual oil kei na vape cartridge.

** 4. Evidence-informed, not evidence-overstating. ** Na vakatovolei section ni vola qo e vakadeitaka na keda commitment me baleta na dina me baleta na ka e tukuna tiko na vakadidike. Keitou vakatavulica na ka e vakadeitaka dina, na ka sa vakavulici, kei na ka sa vakalailai.

Na Vakadidike e Veinikana E Vei Cannabinoid E Na Keda Formula

CBD (Cannabidiol) – 4,500mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Evidence strongest e na veitayagakula [1]-[6].

** Ka e vakadeitaka dina: ** Purified CBD e tiko vua na evidence vakaidina vei ira e epilepsy (FDA-approved Epidiolex) [1][2]. Me baleta na lewe ni Vit e sa bula kei na leqa neurological, oqo e vakatovolei dina.

** Rere: ** Na 2024 systematic review kei meta-analysis e vakadeitaka e 316 participants e vakadidike na kena vinaka, ia e gadrevisa tale na veitovolei [3]. Me baleta na lewe ni Vit e sa rere mai na lawa ni iSulu ni Bula se na vei leqa ni cagibubu, oqo e vakavulici ia sega ni vakadeitaki.

** Cega: ** Na 2024 systematic review e vakadeitaka results e vakavulici ia sega ni vakavotui.

** Moce: ** Na 2023 insomnia review e vakadeitaka na literature e sega ni vakavotui, e vei vakatovolei [5].

** Bula: ** Na 2023 systematic review e vakadeitaka signals me baleta na liver enzyme elevation kei na drug-induced liver injury, e vei vakaidina me baleta na concentrated oral products [6].

CBG (Cannabigerol) – 3,000mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Mostly review-level kei preclinical; human evidence sparse [7][8].

** Pharmacology: ** CBG e biosynthetic precursor me baleta na major cannabinoids, kei na nona iTuvatuva vakalevu e na cannabinoid receptors, alpha-2 adrenoceptors, kei na 5-HT1A pathways [7].

** Research areas: ** Reviews discuss possible relevance vei neurologic disorders, inflammatory bowel disease, antibacterial activity — pharmacology-led hypotheses sega ni human therapeutic conclusions [7][8].

** Vakasama: ** Na 2021 pharmacology review e tukuna vakadua ni CBG e vakasoliasoli commercially ni sa sega ni vakavotui [7].

Delta-8 THC – 6,000mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Pharmacologically relevant, psychoactive, less clinically characterized than delta-9 THC [9]-[11].

** Comparative pharmacology: ** Na 2022 review e vakadeitaka delta-8 kei delta-9 THC tiko na iTuvatuva vakalevu. Delta-8 e partial CB1 agonist, less potent than delta-9 [9].

** Public health: ** Na 2023 scoping review e vakadeitaka na evidence base dominated by animal studies, kei na reports ni adverse consequences kei na regulatory concerns [10].

** Manufacturing: ** Delta-8 interest stems from greater stability kei easier synthesis, raising product-byproduct kei lab-testing concerns [11].

** Vakasama me baleta na Vit: ** Delta-8 THC e treatment tiko me vaka psychoactive THC analogue kei na incomplete human safety characterization.

THCa (Tetrahydrocannabinolic Acid) – 1,500mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Important chemically, ia low on direct human therapeutic evidence [12].

** Ka e tiko kina: ** THCa e acidic precursor me baleta na THC, decarboxylates into THC during heating [12].

** Psychoactivity: ** THCa e sega ni vakayacora psychoactive effects, ia oqo e dina ga ke sega ni decarboxylated [12].

** Research status: ** In vitro kei rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities, ia sega ni vakadeitaka human outcomes [12].

** Me baleta na vei vakatovolei e Vit: ** THCa e best understood me dua na precursor molecule me baleta na kena iTuvatuva vakalevu mai na route, temperature, processing, kei storage.

Delta-9 THC – 90mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Strongest human evidence ni psychoactive cannabinoids, ia clearest adverse-effect burden [1][13]-[15].

** Institutionally supported: ** NCCIH identify THC-containing medicines me baleta na chemotherapy nausea/vomiting, HIV/AIDS appetite/weight loss, kei MS/pain outcomes [1].

** Pain evidence: ** Na 2022 systematic review e vakadeitaka high-THC products e rawa ni solia short-term pain benefit ia increase dizziness, sedation, nausea, kei treatment discontinuation [13].

** Pharmacokinetics: ** Inhaled THC: onset seconds-minutes, peaks 15-30 minutes, lasts few hours. Oral THC: later onset, later peak, longer duration [14].

** Mental health risk: ** Na 2025 systematic review e vakadeitaka consistent unfavorable associations between high-concentration THC products kei psychosis/schizophrenia outcomes, cannabis use disorder, anxiety, kei depression [15].

** Broader safety: ** Anxiety/panic e high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental exposure, vape-related lung injury [1][14][15].

CBN (Cannabinol) – 750mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Weak human evidence; marketing ahead of data [12][16][17].

** Reputation vs. reality: ** Widely marketed me baleta na moce/sedation, ia clinical support e sega ni vakalevu [16][17].

** Sleep claim evaluation: ** Na 2021 narrative review e vakadeitaka NO clinical trials using validated sleep questionnaires se polysomnography [16].

** Broader sleep literature: ** Na 2024 review e vakadeitaka cannabinoid sleep research e sega ni match real-world use scale [17].

CBC (Cannabichromene) – 750mg e na keda sublingual oil

** iTuvatuva vakadidike: ** Emerging, intriguing, overwhelmingly preclinical se review-based [18][19].

** Pharmacology: ** Na 2024 review e tukuna CBC tiko na distinct pharmacodynamics, pharmacokinetics, kei receptor behavior [18].

** Older literature: ** Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance [19].

** Safety caveat: ** Na 2024 CBC review e tukuna over-the-counter CBC products e vakasoliasoli ni sa sega ni vakadeitaka clinical efficacy se safety [18].

Na iTuvatuva Terpene: Na Veiveibuli

Na RSO Talei e sega ni tiko na terpenes — ra vakarusai vakalevu ena heat kei na solvent. Na keitou formulas e vakavulica live terpenes e 5% kei na iTuvatuva e vitu, ni na terpene bioactivity plausible e preclinical level [20][29].

Limonene (citrus-bright)

** iTuvatuva vakadidike: ** Largely review kei preclinical [20]-[22]. Na 2021 review e tukuna antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possibilities [21].

** Bula: ** Limonene oxidation products (hydroperoxides) e allergens [22]. E vakaidina me baleta na climate ni Vit e vakavulica oxidation.

Myrcene

** iTuvatuva vakadidike: ** Mostly preclinical, very limited human data [20][23]. Na 2021 review e tukuna anxiolytic, antioxidant, anti-inflammatory, analgesic properties ia human studies lacking [23].

Caryophyllene (β-caryophyllene – pepper/spice)

** iTuvatuva vakadidike: ** Among the most mechanistically interesting terpenes ni direct CB2 receptor agonism, ia mostly preclinical [24]. Na 2021 review e highlight anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions [24].

Pinene (forest-fresh)

** iTuvatuva vakadidike: ** Promising preclinical, weak human confirmation [20][25]. Na 2021 review e gadrevisa clinical trials [25].

Linalool (floral, lavender)

** iTuvatuva vakadidike: ** Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. Na 2021 brain-health review e gadrevisa robust human trials [25].

** Bula: ** Oxidized linalool hydroperoxides e allergens [22] — vakaidina me baleta na climate ni Vit.

Humulene (earthy, woody)

** iTuvatuva vakadidike: ** Translationally interesting ia early [20][27]. Na 2024 scoping review e vakadeitaka broad preclinical anti-inflammatory evidence [27].

Terpinolene (piney, fruity, sparkling)

** iTuvatuva vakadidike: ** One of the least clinically characterized terpenes [20][28]. Na 2021 systematic review e vakadeitaka evidence base dominated by in silico, in vitro, kei animal studies [28].

Veilabati ni Vakadidike

E rima na lawa vakaidina me vakatavulica:

1. ** Evidence e uneven highly. ** CBD kei delta-9 THC support the most detailed statements.
2. ** Extract types e sega ni interchangeable. **
3. ** Minor cannabinoids e commercially interesting BECAUSE underexplored. **
4. ** Product quality matters me yacova molecule identity. **
5. ** THCa chemistry changes with storage/heating. ** E vakaidina me baleta na climate vakaloloma ni Vit [12].

Na Keda RSO Sublingual Oil Formula: Vakadeitaki Vakayalodina

Oqo na keda flagship product. Keitou vakapublica na formula vakatotolo ni ko vinakata na ka kece e kila.

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
** Total Cannabinoids **	** 16,590mg **

• ** Live Terpenes: ** 5%
• ** Format: ** 30mL bottle
• ** Active cannabinoids per mL: ** 553mg
• ** Carrier: ** Organic MCT oil
• ** Onset: ** 15-45 minutes (sublingual)
• ** Duration: ** 4-6 hours
• ** Bioavailability: ** 13-19%
• ** Price: ** $129.99 USD
• ** Approximate doses per bottle: ** 40-60

** Me baleta na vei vakatovolei e Vit: **

• E 553mg/mL, oqo e concentrated formula — sega ni gadrevisa na massive daily doses ni Simpson
• E 90mg total delta-9 THC e vakavulica me Farm Bill compliant
• E 1,500mg THCa e vakavulica — ko oqo e vakatovolei: vakayagataka raw se decarboxylate
• Organic MCT oil e solia clean absorption

Na Keda RSO Vape Cartridge Formula: Fast Relief

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• ** Live Terpenes: ** 5%+
• ** Format: ** 1 Gram cartridge
• ** Battery compatibility: ** 510-thread universal
• ** Onset: ** 1-2 minutes
• ** Duration: ** 2-4 hours
• ** Bioavailability: ** 10-35%
• ** Price: ** $49.99 USD
• ** Automatic THCa decarboxylation: ** Occurs e vaping temperature (400-450°F)

** Me baleta na vei vakatovolei e Vit e gadrevisa fast relief: **

• Na vape e ideal me baleta na breakthrough pain, acute nausea, se panic attacks
• Compact kei discreet me baleta na travel

Na Veitovolei Decarboxylation: Na Nomuni Vakavulica

** Option 1 — Raw, sega ni heat: ** Vakayagataka na sublingual oil as-is. E 1,500mg e tiko me THCa — completely non-psychoactive, perfect me baleta na daytime use.

** Option 2 — Fully activated, home decarboxylation: ** Vakavulica na waiwai e 260°F (125°C) e 45-60 minutes e oven-safe glass container. Oqo converts 1,500mg THCa into approx 1,315mg delta-9 THC. Vata kei na 90mg delta-9 THC, ko rawa ni 1,405mg total delta-9 THC. Vata kei na 6,000mg delta-9 THC, oqo e psychoactive potency comparable to traditional illegal RSO — 100% legally.

** Option 3 — Partial control: ** Vakaseqetaka e dua na waiwai ki na dua container kei decarboxylate ga na ko vinakata.

** Option 4 — Vape: ** Na cartridge auto-decarboxylates e vaping temperature.

** Conversion chemistry: ** 1mg THCa = 0.877mg delta-9 THC ni sa oti na decarboxylation.

Condition-Specific Usage Context Me Baleta Na Vit

** Vakadinadinataka: ** Oqo e contexts e vakayacora ena vakadidike ni cannabinoid e tukuni ena vola. E sega ni medical prescriptions, sega ni FDA-approved, sega ni substitutes for professional medical care. Always consult qualified healthcare provider. Do not operate vehicles or machinery while under the influence.

** Chemotherapy-related nausea kei appetite support: **

• Pre-chemo: 0.5-1.0mL sublingual approx 1 hour before
• Acute breakthrough nausea: 2-3 vape puffs
• Post-chemo: 0.5mL sublingual e veisiga ono
• Sleep support: 1.0-2.0mL sublingual before bed

** Chronic pain (fibromyalgia, arthritis, neuropathy): **

• Daytime: 0.3-0.5mL raw sublingual (anti-inflammatory without impairment)
• Nighttime: 0.5-1.0mL decarboxylated sublingual
• Breakthrough pain: Vape as needed

** Sleep support: **

• Before bed: 1.0-2.0mL sublingual
• E 2.0mL: delivers 50mg CBN
• E 1.0mL: delivers 25mg CBN

** Anxiety kei stress: **

• Daytime functional relief: 0.3mL raw sublingual (CBD + CBG without impairment)
• Nighttime: 1.0mL sublingual

** General titration principle: ** Start low, go slow. Begin e 0.25-0.5mL sublingual ka vakatavulica na kena iYalayala e 2-3 hours before increasing.

Vakasoliasoli Vei Viti: Kena Vakacavataki

** International shipping process: **

• Keitou vakasoliasoli ki Viti via USPS Priority Mail International (6-10 business days) se FedEx International (3-5 business days)
• All packages include full documentation: COAs, receipts, customs declarations
• ** Important: ** Na iTavi ni customer me vakadeitaka legality e Viti ka vakadonuya na customs kei legal risk
• Contact keitou e (832) 416-2816 se [email protected] me baleta na Fiji-specific shipping quotes

** Fiji customs: **

• Na products e tawa ni 0.3% delta-9 THC, meeting 2018 U.S. Farm Bill
• Na THCa content (1,500mg) e non-psychoactive until heated
• Fiji’s import laws e rawa ni rui sava; keitou recommend checking with Fiji’s customs authority
• Keitou provide documentation needed for customs clearance, ia sega ni guarantee entry

** Currency kei payment: **

• Prices e USD ($129.99 for sublingual oil, $49.99 for vape cartridge)
• International credit cards accepted
• PayPal available

** Discreet packaging: **

• Sega ni cannabis branding visible
• Plain brown box se envelope
• Product descriptions use technical/chemical names

Bula, iTuvatuva, kei na Legal Framework

** Age requirement: ** 21+ for all RSO products

** THC content compliance: ** E tawa ni 0.3% delta-9 THC by dry weight, Farm Bill compliant.

** FDA disclaimers: ** Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease.

** Safety warnings: **

• May cause drowsiness se impairment. Do not operate boats, vehicles, se machinery.
• Consult healthcare provider before use.
• Keep out of reach of children kei na pets.
• For raw THCa use: individual responses vary. Start small.
• For decarboxylated use: psychoactive effects can be strong. Use in safe environments.

** Buyer responsibility: ** Na customers e Viti era vakayacora me vakadeitaka local laws. OilWell assumes no legal responsibility. Void where prohibited.

** Quality assurance: ** All products undergo third-party lab testing for potency, heavy metals, pesticides, residual solvents, microbial contaminants. COAs available.

Na Keda iTukutuku Ni Media

** Media track record: **

• Seven ABC13 features (2019-2023)
• Five different reporters
• Featured as primary cannabis industry expert

** Key moments: **

• September 2019: “I’m not trying to sell people snake oil…”
• May 2021: Iconic moment of radical honesty about Delta-8
• August 2021: $35,000 in product giveaway for COVID-19 vaccination
• October 2021: Proactive removal of Delta-8 products when Texas banned
• October 2022: Personal revelation about Colin’s marijuana conviction history
• April 2023: Framed present as “Renaissance”

Na iYalayala Open-Source: Na Vuna Keitou VakaPublica

Keitou vakapromisa complete transparency. Na formulas e open-source. Keitou solia the CBD golden paste recipe:

** CBD Golden Paste Recipe: **

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 teaspoons freshly ground black pepper
• CBD oil (dosage depends on pet size; consult veterinarian)

** Instructions: ** Mix turmeric kei water e saucepan over low heat until thick paste (7-10 minutes). Add coconut oil kei pepper. Cool kei store refrigerated up to two weeks. Mix small amount with pet food 1-2x daily. Consult veterinarian first.

Na Vakadidike E Veinikana E Na Formulas Me Baleta Na Vit

Every cannabinoid kei terpene e vakadeitaka e na research section. Keitou sega ni exempt keda. When our RSO guide makes specific research claims, you can trace them back.

** Practical takeaways: **

• CBD kei delta-9 THC evidence strongest
• Delta-8 THC psychoactive ia less characterized
• THCa changes with processing (critical in Vit’s warm climate)
• CBG, CBN, CBC scientifically credible ia clinically immature
• Terpene claims should be careful

** Me baleta na lewe ni Vit e leqataka chronic pain: **
Start e 0.3mL raw sublingual oil during work hours. Add 0.5mL decarboxylated oil at night. Vape for breakthrough pain.

** Me baleta na veterans kei trauma survivors: **
Daytime: 0.3mL raw sublingual. Nighttime: 1.0mL sublingual decarbed se vape.

** Me baleta na cancer patients: **
Use 0.5-1.0mL sublingual 1 hour before chemo. Vape for breakthrough nausea. Nighttime: 1.0-2.0mL.

** Me baleta na elders: **
Raw sublingual oil provides anti-inflammatory benefits without cognitive impairment.

Na Noda iTukutuku Vakayacori Me Baleta Na IYasana Ni Vit

Mai na Texas-Mexico border e vakavulici Colin ki na veiyasana ni Vit e wilika oqo, na ka e vakatavulica keitou e dina: na tamata e vinakata na veisau vakadodonu ni sa bale na iVakavuvuli ni Bula. Whether you’re in Suva dealing with chronic pain, in Nadi navigating cancer, or in a village on Vanua Levu seeking sleep relief — you deserve education, not hype.

Na keda commitment ki Viti:

• Legal, Farm Bill-compliant products
• Complete formula transparency
• Evidence-based education
• Patient-controlled potency
• Community-first values

** Is RSO right for you? ** Keitou sega ni kila. Ia keitou promise me solia vei kemuni na information me vakayacora na veitovolei vinaka ka decide vakaiyalayala.

** Vinaka vakalevu ** me baleta na wilika. Keitou tiko kea me vukei.

** Contact Information: **

• Phone: +1 (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
• Instagram: @oilwellcbd
• Business Hours: Mon-Thu 10AM-7PM, Fri-Sat 10AM-10PM, Sun 10AM-4PM (CST, UTC-6)

** Physical Location: ** 810 Richmond Ave, Houston, TX 77006, USA

** Fiji Customer Support: ** When contacting keitou from Fiji, please note location for accurate shipping estimates.

** Legal Notice: ** All Fiji customers responsible for verifying local laws. OilWell Cannabis assumes no legal responsibility. Products sold as hemp-derived wellness products, sega ni medicines.

ENGLISH

Rick Simpson Oil (RSO) in Fiji: The Complete Guide by OilWell Cannabis

Bula, Fiji. If you’re reading this from Suva, Nadi, Lautoka, or anywhere across the beautiful islands of our Pacific nation, you’re likely here for one reason: you need honest answers about Rick Simpson Oil. Maybe you’ve heard the stories — the legacy of a Canadian engineer who believed concentrated cannabis oil could help when conventional medicine fell short. Perhaps you’re dealing with chronic pain from years of physical work in Fiji’s tourism or agricultural sectors. Maybe you’re a veteran struggling with PTSD, a cancer patient exploring every possible option, or simply someone who can’t sleep through our humid tropical nights and is tired of pharmaceutical solutions that don’t work.

We understand. We’re OilWell Cannabis, and we’re here to give you what we wish we’d had when we started this journey: complete, evidence-based education about RSO — what it actually is, what the science really says, and how our modern, multi-cannabinoid formulas can serve Pacific communities like yours.

What Is Rick Simpson Oil, Really?

Let’s start with the truth, because that’s what you deserve. Rick Simpson was not a doctor. He was a power engineer from Nova Scotia, Canada, born in 1949, who fell from scaffolding in 1997 and suffered a head injury that left him with persistent tinnitus and post-concussion symptoms. When the medications his doctors prescribed made things worse, he turned to cannabis. When he asked his physician to consider cannabis as an option, the answer was no .

In 2003, Simpson claimed that three bumps on his arm — diagnosed as basal cell carcinoma — disappeared after he applied concentrated cannabis oil directly to them and covered them with bandages for four days. No biopsy confirmed this. No independent medical documentation exists. But this personal experience became the origin story of “Rick Simpson Oil” and launched a global movement .

Important context: Simpson’s account is personal testimony, not medical evidence. It cannot be evaluated as clinical proof, but it is historically significant as the catalyst for a worldwide conversation about concentrated cannabis oil.

After his 2003 experience, Simpson committed himself to producing and distributing oil for free to cancer patients and others in his community. He claimed to help people with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more . His 2005 documentary Run From The Cure spread his story globally, becoming foundational in cannabis communities. But his advocacy brought him into direct conflict with Canadian law — RCMP raids in 2005 and 2009, criminal charges, and eventually relocation to Europe .

Throughout his public career, Simpson maintained that cannabis oil could cure cancer and that pharmaceutical companies and government agencies were actively suppressing this knowledge. He framed his work as fighting institutional corruption . What he got right: he drew attention to cannabinoids as a serious biomedical research area when the world was ignoring it. What he overstated: his cure claims exceeded the evidence, and encouraging patients to use RSO instead of proven cancer therapies carries genuine harm potential .

The Traditional RSO Protocol: What Simpson Recommended

Simpson designed a specific treatment protocol: 60 grams of concentrated oil consumed over approximately 90 days . Here’s exactly what he recommended:

• Week 1: Dose the size of half a grain of rice (10-15mg) three times daily
• Weeks 2-5: Double dose every four days, aiming for 1 gram (1,000mg) per day by week five
• Weeks 5-12: Maintain 1 gram daily, divided into three doses
• Administration: Primarily oral (sublingual or swallowed), topical for skin lesions
• Tolerance: Simpson claimed patients develop THC tolerance in 3-4 weeks, with psychoactive effects being temporary
• Maintenance: After completing 60 grams, 1-2 grams monthly indefinitely

Critical context for evaluating this protocol:

• No controlled trial validation exists
• Traditional RSO was crude, unstandardized material with unknown potency
• Peak dosing delivers approximately 600-900mg of delta-9 THC daily — far exceeding anything studied clinically [13][14][15]
• Real risks at these doses include severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][15]
• Cancer patients are medically complex; using unregulated oil as primary treatment introduces harm beyond the oil itself

For our friends in Fiji dealing with serious health conditions, this protocol context is essential. We respect Simpson’s historical contribution, but modern science and safety must guide your decisions.

What Traditional RSO Actually Was: The Product

Traditional RSO was defined by method, not lab standards:

• Source: Single high-THC indica strain, no standardization
• Extraction: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade
• Process: Bucket, solvent wash, filter, rice cooker evaporation, syringe storage
• Appearance: Nearly black, thick, tar-like oil with possible solvent-residual smell
• Cannabinoids: 60-90% delta-9 THC (estimated), fully decarboxylated, no ratio control
• Terpenes: Effectively destroyed by solvent + heat process
• Standardization: None — every batch different
• Testing: None — no COAs, no contaminant screening
• Residual solvent risk: Naphtha may contain benzene, toluene, other carcinogens

The gap between what RSO was and what people think it is creates confusion from Suva to Lautoka to Nadi. Many products labeled “RSO” today bear little resemblance to Simpson’s original.

Why OilWell’s Formulas Diverge from Traditional RSO

We’re not here to replicate Simpson’s oil — we’re here to evolve it using modern science while honoring his accessibility ethos. Here’s how our approach addresses the limitations of traditional RSO:

Multi-cannabinoid approach: Traditional RSO relied on whatever single strain was available. Our formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited [20][29].

Terpene preservation: Traditional RSO had essentially no terpenes. We include live terpenes at 5% with a defined seven-terpene profile: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each terpene has its own evidence profile discussed below.

THCa as separate ingredient: Traditional RSO fully decarboxylated everything. We preserve THCa at 1,500mg because the THCa literature suggests potentially relevant non-psychoactive bioactivity that is lost when it converts to THC [12].

Reduced delta-9 THC dominance: Traditional RSO was 60-90% delta-9 THC. Our formula contains only 90mg delta-9 THC total, distributed across 16,590mg of total cannabinoids. This reflects broader cannabinoid research rather than single-compound dominance.

Product format innovation: Simpson envisioned only oral oil. We offer both sublingual oil and vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Safety evolution: Traditional RSO used toxic solvents. Our production is solvent-free, using food-grade MCT oil carrier with full third-party lab testing for potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants.

Evidence standards: Simpson relied on anecdote. We rely on peer-reviewed literature with clear evidence hierarchies [1]-[29].

The Origin of OilWell Cannabis: A Story That Matters to Fiji

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But our story doesn’t start in a boardroom — it starts with a dog named Bentley.

Colin grew up in McAllen, Texas, along the dangerous U.S.-Mexico border. He learned cannabis in the traditional underground world, seeing friends killed or imprisoned. He could have taken darker paths, but he chose cannabis. He later became a software engineer and did custom development for Baylor College of Medicine — one of America’s most prestigious medical institutions. That combination of deep plant knowledge and medical-grade technical precision defines everything we do.

Bentley’s story is our foundation. When Bentley, Colin’s beloved companion, became paralyzed and veterinarians recommended euthanasia, Colin refused. A rescue worker asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin created a CBD golden paste formula for Bentley. From paralysis and facing death, Bentley got up, walked over, and brought Colin his ball to play. Dogs don’t respond to placebo. That was real. Bentley lived ten more years, passing naturally at age twenty.

During those ten years, Colin developed specialized formulas for every condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. This is why our RSO has seven cannabinoids — born from necessity, not marketing.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. He quit Xanax cold turkey using the cannabinoid knowledge he developed keeping Bentley alive. Our Peace Gummies formula was created during midnight experiments while fighting benzo withdrawal. Colin personally uses the vape form for his insomnia and severe PTSD. This is not theoretical — he lived what RSO patients live.

We’ve developed formulas that doctors use for Crohn’s, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. Our focus has always been making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

What Makes Our RSO Different: Four Core Principles

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide across the U.S. and internationally to Fiji and other Pacific nations where hemp-derived products are legal. Rick Simpson believed medicine should be accessible; we built a legal distribution model that makes that real.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw (zero impairment) or decarboxylate it into delta-9 THC for full psychoactive potency. Rick Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish our complete formulas publicly — every cannabinoid, every milligram, every percentage. If you cannot afford our products, you can source ingredients and make your own. Rick Simpson gave his oil away for free; we adapted that ethos for the modern marketplace by selling a professionally manufactured product AND publishing the recipe. Later in this guide, we provide the exact formulas for both our sublingual oil and vape cartridge.

4. Evidence-informed, not evidence-overstating. The research section of this document represents our commitment to honesty about what the science actually says. We distinguish between what’s well-supported, what’s emerging, and what’s overstated. You deserve that clarity, whether you’re in Houston or Suva.

The Science Behind Every Cannabinoid in Our Formula

CBD (Cannabidiol) – 4,500mg in our sublingual oil

Evidence profile: Strongest human evidence in our formula [1]-[6].

What’s best supported: Purified CBD has the most credible human evidence in seizure disorders (FDA-approved Epidiolex) [1][2]. For Fiji residents dealing with epilepsy or other neurological conditions, this is the most validated non-psychoactive option.

Anxiety: A 2024 systematic review and meta-analysis covering 316 participants found statistically significant anxiolytic effects, though authors stress more trials are needed before broad conclusions [3]. For Fijians dealing with stress from economic pressures or the aftermath of tropical storms, this is promising but not yet definitive.

Pain: A 2024 systematic review found promising but heterogeneous results, with trial quality limiting broad analgesic claims [4]. For chronic pain from physical labor common in Fiji’s agricultural and tourism sectors, CBD offers potential but requires realistic expectations.

Sleep: A 2023 insomnia review found the literature methodologically weak, with few objective sleep assessments [5]. For those struggling with sleep in Fiji’s humid climate, CBD may help but isn’t a guaranteed solution.

Safety: A 2023 systematic review found real signals for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products [6]. NCCIH also flags diarrhea, sleepiness, appetite changes, mood effects, and drug interactions [1].

CBG (Cannabigerol) – 3,000mg in our sublingual oil

Evidence profile: Mostly review-level and preclinical; human evidence sparse [7][8].

Pharmacology: CBG is the biosynthetic precursor to major cannabinoids, with distinct interactions at cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A pathways [7]. For Fiji’s wellness community interested in novel compounds, this is mechanistically interesting but not yet clinically established.

Research areas: Reviews discuss possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity — primarily pharmacology-led hypotheses rather than human therapeutic conclusions [7][8].

Caution: A 2021 pharmacology review explicitly notes CBG is being sold commercially while the evidence base remains thin [7]. For Fiji consumers, this means marketing often outruns science.

Delta-8 THC – 6,000mg in our sublingual oil

Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].

Comparative pharmacology: A 2022 review concluded delta-8 and delta-9 THC have broadly similar behavior. Delta-8 is a partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9]. For Fiji users seeking milder psychoactive effects, this is relevant.

Public health: A 2023 scoping review found the evidence base dominated by animal studies and product chemistry, with reports of adverse consequences and regulatory concerns [10].

Manufacturing: Delta-8 interest stems from greater stability and easier synthesis relative to naturally scarce plant levels, raising product-byproduct and lab-testing concerns [11].

Bottom line for Fiji: Delta-8 THC should be treated as a psychoactive THC analogue with real pharmacologic activity but incomplete human safety characterization and manufacturing-quality uncertainty [9]-[11].

THCa (Tetrahydrocannabinolic Acid) – 1,500mg in our sublingual oil

Evidence profile: Important chemically, but low on direct human therapeutic evidence [12].

What it is: THCa is the acidic precursor to THC and represents much of the THC-related content in raw plant material. It decarboxylates into THC during heating and can change during storage [12].

Psychoactivity: THCa itself does not produce psychoactive effects, but this distinction only holds if it stays acidic and isn’t substantially decarboxylated [12].

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities, but these aren’t established human outcomes [12].

For Fiji users: THCa is best understood as a precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage. Our product’s unique feature is that YOU control whether it stays non-psychoactive (raw) or converts to THC (heated).

Delta-9 THC – 90mg in our sublingual oil

Evidence profile: Strongest human evidence of psychoactive cannabinoids, but clearest adverse-effect burden [1][13]-[15].

Institutionally supported: NCCIH identifies THC-containing medicines as relevant to chemotherapy nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS/pain outcomes, while stressing many other uses remain uncertain [1].

Pain evidence: A 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13]. For Fiji’s chronic pain community, this tradeoff is critical to understand.

Pharmacokinetics: Inhaled THC: onset seconds-minutes, peaks 15-30 minutes, lasts few hours. Oral THC: later onset, later peak, longer duration [14]. This matters for both benefit and overconsumption risk.

Mental health risk: A 2025 systematic review found consistent unfavorable associations between high-concentration THC products and psychosis/schizophrenia outcomes, cannabis use disorder, anxiety, and depression [15].

Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, withdrawal, pregnancy concerns, accidental exposure, vape-related lung injury [1][14][15].

CBN (Cannabinol) – 750mg in our sublingual oil

Evidence profile: Weak human evidence; marketing ahead of data [12][16][17].

Reputation vs. reality: Widely marketed for sleep/sedation, but clinical support is far thinner than the market suggests [16][17].

Sleep claim evaluation: A 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles, and found NO clinical trials using validated sleep questionnaires or polysomnography that could substantiate strong sleep-promoting claims [16].

Broader sleep literature: A 2024 review concluded cannabinoid sleep research still doesn’t match real-world use scale, with need for better-designed, adequately powered trials [17].

Chemical context: THC can degrade toward CBN under certain conditions, which helps explain why CBN appears in aging cannabis [12].

For Fiji users: CBN is one of the clearest examples where cultural reputation is stronger than current clinical evidence [16][17].

CBC (Cannabichromene) – 750mg in our sublingual oil

Evidence profile: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].

Pharmacology: A 2024 review argues CBC has distinct pharmacodynamics, pharmacokinetics, and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as especially interesting research targets [18].

Older literature: Review literature reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, and possible neurobiological/antiproliferative relevance, but these aren’t strong patient-facing claims [19].

Safety caveat: The 2024 CBC review explicitly notes over-the-counter CBC products are being sold despite little evidence establishing clinical efficacy or safety [18].

For Fiji researchers: CBC belongs in the category of scientifically credible minor cannabinoids deserving more research, not already-validated clinical actives [18][19].

The Terpene Profile: Beyond Cannabinoids

Traditional RSO had no terpenes — they were destroyed by heat and solvent. Our formulas include live terpenes at 5% with a specific seven-terpene profile, because terpene bioactivity is plausible at the preclinical level, even if robust human clinical confirmation for cannabis-specific effects remains limited [20][29].

Limonene (citrus-bright)

Evidence: Largely review and preclinical [20]-[22]. A 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, and immune-modulatory possibilities, but most claims come from nonhuman literature [21].

Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens [22]. For Fiji’s tropical climate where oxidation accelerates, this matters.

Myrcene

Evidence: Mostly preclinical, very limited human data [20][23]. A 2021 review describes anxiolytic, antioxidant, anti-inflammatory, and analgesic properties but explicitly states human studies are lacking [23].

Interpretation: Myrcene is often invoked as a proven sedating terpene explaining “couch-lock.” This is stronger than current human evidence supports [20][23].

Caryophyllene (β-caryophyllene – pepper/spice)

Evidence: Among the most mechanistically interesting terpenes due to direct CB2 receptor agonism, but still mostly preclinical [24]. A 2021 review highlights anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, and gastroprotective actions [24].

Why it matters for Fiji: Beta-caryophyllene is arguably the strongest candidate for a terpene with cannabinoid-system significance, which may complement our formula’s multi-cannabinoid approach [24].

Pinene (forest-fresh)

Evidence: Promising preclinical, weak human confirmation [20][25]. A 2021 review found antioxidant, anti-inflammatory, and neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].

Claims: That pinene reliably improves memory or counterbalances THC cognitive effects remain interesting hypotheses, not settled facts [20][25].

Linalool (floral, lavender)

Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. A 2021 brain-health review found enough preclinical signal to justify continued investigation, while stressing lack of robust human trials [25].

Safety: Oxidized linalool hydroperoxides are recognized allergens [22] — relevant for Fiji’s climate.

Humulene (earthy, woody)

Evidence: Translationally interesting but early [20][27]. A 2024 scoping review of 340 articles found broad preclinical anti-inflammatory evidence, with some rodent work suggesting cannabimimetic properties [27].

Bottom line: Valuable for hypothesis generation, but doesn’t yet establish consistent human efficacy [27].

Terpinolene (piney, fruity, sparkling)

Evidence: One of the least clinically characterized terpenes in our profile [20][28]. A 2021 systematic review screened 2,449 records, concluding the evidence base is dominated by in silico, in vitro, and animal studies rather than human trials [28].

For Fiji: Terpinolene is biologically interesting but especially underdeveloped clinically [20][28].

Research Limits and Why Honesty Matters for Fiji

Five critical interpretation rules guide our approach:

1. Evidence is highly uneven. CBD and delta-9 THC support the most detailed statements; the rest require more caution [1]-[29].

2. Extract types aren’t interchangeable. Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not the same. A common error is letting evidence from one category stand for another.

3. Minor cannabinoids are commercially interesting BECAUSE they’re underexplored. That also means claims around them often become inflated relative to the actual science.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].

5. THCa chemistry changes with storage/heating. For Fiji’s tropical climate where temperatures can accelerate chemical changes, this is especially relevant [12].

These limits are why we refuse to overstate. You deserve honesty, whether you’re in Houston or Suva.

Our RSO Sublingual Oil Formula: Complete Transparency

This is our flagship product. We publish the complete formula because you deserve to know exactly what you’re putting in your body.

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5% (limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene)
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg
• Carrier: Organic MCT oil
• Onset: 15-45 minutes (sublingual)
• Duration: 4-6 hours
• Bioavailability: 13-19%
• Price: $129.99 USD
• Approximate doses per bottle: 40-60 depending on serving size

What this means for Fiji users:

• At 553mg/mL, this is a highly concentrated formula — no need for the massive daily doses Simpson recommended
• The 90mg total delta-9 THC keeps it Farm Bill compliant for international shipping
• The 1,500mg THCa gives you control: use raw for non-psychoactive daytime relief or decarboxylate for full psychoactive potency
• Organic MCT oil provides clean absorption and neutral taste, unlike traditional RSO’s tar-like consistency

Our RSO Vape Cartridge Formula: Fast Relief

For breakthrough symptoms requiring immediate action, our vape format delivers the same multi-cannabinoid approach in seconds.

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge
• Battery compatibility: 510-thread universal
• Onset: 1-2 minutes (fastest delivery)
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Price: $49.99 USD
• Automatic THCa decarboxylation: Occurs at vaping temperature (400-450°F)

For Fiji users needing rapid relief:

• The vape is ideal for breakthrough pain, acute nausea, or panic attacks
• Every puff delivers freshly decarboxylated cannabinoids
• Compact and discreet for travel between islands
• Works with standard vape batteries available in Fiji’s urban centers

The Decarboxylation Choice: Your Power, Your Control

This is the innovation that makes our product uniquely suitable for Fiji’s diverse community needs.

Option 1 — Raw, no heat: Use the sublingual oil as-is. All 1,500mg stays as THCa — completely non-psychoactive, perfect for daytime use while working in Fiji’s tourism industry, driving, or caring for family. Provides anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12].

Option 2 — Fully activated, home decarboxylation: Heat the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500mg THCa into approximately 1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, you get approximately 1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, this achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because you control the activation.

Option 3 — Partial control: Transfer a portion of oil to a separate container and decarboxylate only what you need, preserving the remainder raw.

Option 4 — Vape: The cartridge auto-decarboxylates at vaping temperature, delivering instant relief.

Conversion chemistry: 1mg THCa = 0.877mg delta-9 THC after decarboxylation (accounting for CO₂ loss).

For Fiji’s community of professionals who cannot be impaired during work hours, this is revolutionary. For patients who need full-strength relief at night, it’s equally powerful. You choose.

Condition-Specific Usage Context for Fiji

Important disclaimer: These contexts are informed by cannabinoid research cited throughout this document. They are not medical prescriptions, not FDA-approved, and not substitutes for professional medical care. These products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support:

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea/vomiting [1][13], CBD anxiolytic buffering [3]

Chronic pain (fibromyalgia, arthritis, neuropathy) — common among Fiji’s agricultural and tourism workers:

• Daytime: 0.3-0.5mL raw sublingual (anti-inflammatory without impairment)
• Nighttime: 0.5-1.0mL decarboxylated sublingual (pain relief + CBN sleep support)
• Breakthrough pain: Vape as needed
• Evidence: CBD pain [4], delta-9 THC pain [13], caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep support — crucial in Fiji’s humid climate:

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: delivers 50mg CBN (dosage investigated in 2024 sleep literature)
• At 1.0mL: delivers 25mg CBN (above 20mg threshold associated with reduced sleep disturbance)
• Evidence: CBN sleep [16][17], cannabis and sleep review [17]

Anxiety and stress:

• Daytime functional relief: 0.3mL raw sublingual (CBD + CBG without impairment)
• Nighttime: 1.0mL sublingual (full profile including CBN)
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage effect [20]

General titration principle for Fiji users: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Shipping to Fiji: How to Access Our Products

We understand that Fiji’s geographic isolation creates unique challenges for accessing specialized wellness products. Here’s exactly how we serve Pacific communities:

International shipping process:

• We ship to Fiji via USPS Priority Mail International (typically 6-10 business days) or FedEx International (3-5 business days)
• All packages include full documentation: Certificates of Analysis (COAs), receipts, and customs declarations
• Important: The customer is responsible for verifying legality in Fiji and accepts all customs and legal risk
• Contact us at (832) 416-2816 or [email protected] for Fiji-specific shipping quotes

What you need to know about Fiji customs:

• Our products contain less than 0.3% delta-9 THC at point of sale, meeting the 2018 U.S. Farm Bill definition of hemp
• The THCa content (1,500mg) is non-psychoactive until heated
• Fiji’s import laws regarding hemp-derived cannabinoids may differ from U.S. law; we recommend checking with Fiji’s customs authority before ordering
• We provide all documentation needed for customs clearance, but cannot guarantee entry into Fiji — customers assume this responsibility

Currency and payment:

• Prices in USD ($129.99 for sublingual oil, $49.99 for vape cartridge)
• International credit cards accepted
• PayPal available for Fiji customers

Discreet packaging:

• No cannabis branding visible on external packaging
• Plain brown box or envelope
• Product descriptions use technical/chemical names for customs purposes

We have successfully shipped to Pacific islands and understand the unique logistics. Our PANDEM1C SEO technology (14 million locations, 300+ AI models) helps us connect with Fiji customers searching for RSO in their own terms.

Safety, Compliance, and Legal Framework for Fiji Users

Age requirement: 21+ for all RSO products

THC content compliance: All products contain less than 0.3% delta-9 THC by dry weight, making them Farm Bill compliant under U.S. federal law. This is what enables international shipping.

FDA disclaimers: Not evaluated by FDA. Not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary. These statements have not been evaluated by the Food and Drug Administration.

Safety warnings for Fiji:

• May cause drowsiness or impairment. Do not operate boats, vehicles, or machinery while under the influence — especially important in Fiji where water and road travel are daily necessities.
• Consult your healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing.
• Keep out of reach of children and pets.
• For raw THCa use: while non-psychoactive, individual responses vary. Start with small doses.
• For decarboxylated use: psychoactive effects can be strong. Use in safe, comfortable environments.

Buyer responsibility: Fiji customers are responsible for verifying local laws regarding hemp-derived products. OilWell assumes no legal responsibility for your use or decarboxylation decisions. Void where prohibited by law.

Quality assurance: All products undergo third-party lab testing for:

• Potency testing (HPLC/UHPLC analysis, ±2% accuracy)
• Heavy metals screening (arsenic, cadmium, lead, mercury below FDA limits)
• Pesticide analysis (400+ compound screening)
• Residual solvents (FDA Class 3 limits <5,000 ppm)
• Microbial testing (E. coli, Salmonella, Aspergillus, etc.)

COAs available on request and on our website.

Our Media Recognition: Why It Matters for Fiji

You might wonder why ABC13 Houston news features matter to someone in Fiji. Here’s why: mainstream media validation from a major U.S. network affiliate (America’s 4th-largest city) establishes credibility that transcends geography. When five different reporters seek you out over four years for seven distinct features covering business, law, medicine, community health, and politics, that recognition cannot be purchased — it can only be earned.

Our media track record:

• Seven ABC13 features (2019-2023) covering Texas marijuana law, Delta-8 legal analysis, COVID-19 community health leadership, criminal justice reform, and cannabis business pioneering
• Five different reporters: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, KTRK staff
• Featured as primary cannabis industry expert for Houston’s 2.3 million residents

Key moments that define our character:

• September 2019: Our foundational quote — “I’m not trying to sell people snake oil… I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” This honesty remains our north star.

• May 2021: Steve Campion’s investigative feature on Delta-8 included Colin’s iconic moment of radical honesty: “I don’t give a sh** if it’s wrong to say you’ll get high off it. Maybe you want to get high.” ABC13 aired this uncensored, demonstrating our commitment to truth over sanitized marketing.

• August 2021: We gave away approximately $35,000 in product (1,000 caviar pre-rolls) to encourage COVID-19 vaccination, coordinating with the city of Houston. No political agenda — just community health.

• October 2021: When Texas banned Delta-8 overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed major revenue loss to act ethically.

• October 2022: The most personal revelation — Colin has a personal marijuana conviction history. This transforms every quote: we’re not outside entrepreneurs; we’re people who’ve lived the consequences and built a legal business with integrity.

• April 2023: Our most recent feature framed the present as a “Renaissance” — a time of opportunity that should be enjoyed now, not just waited for.

For Fiji customers, this media record means you’re dealing with a company that has been vetted by major-market journalism across four years of industry evolution. That’s credibility most online cannabis brands cannot claim.

The Open-Source Promise: Why We Publish Everything

We promised complete transparency, and here it is. Our formulas are open-source. If you can source the individual cannabinoid distillates and isolates, you can make your own version. This is our direct continuation of Rick Simpson’s free-distribution ethos, adapted for the modern cannabinoid marketplace.

Why we do this:

• Some Fiji families cannot afford $129.99 USD for the sublingual oil
• Some prefer the control of making their own medicine
• This is about access, not just sales
• We sell a professionally manufactured, lab-tested product for those who want it
• We publish the recipe for those who need to make it themselves

The formulas are already published above in the “RSO Sublingual Oil” and “RSO Vape Cartridge” sections. Every milligram, every percentage, every detail is there.

We also publish the original CBD golden paste recipe that saved Bentley’s life — so any pet owner in Fiji facing a similar crisis can make it:

CBD Golden Paste Recipe:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup unrefined organic coconut oil
• 1-2 teaspoons freshly ground black pepper (critical for absorption)
• CBD oil (dosage depends on pet size; consult veterinarian)

Instructions: Mix turmeric and water in saucepan over low heat until thick paste (7-10 minutes). Add coconut oil and pepper. Cool and store refrigerated up to two weeks. Mix small amount with pet food 1-2x daily. Always consult veterinarian first.

This recipe is free, proven, and published because Bentley’s story taught us that sharing knowledge saves lives — whether in Houston or Fiji.

How the Evidence Connects to Our Formulas for Fiji

Every cannabinoid and terpene in our formulas has its evidence profile documented in the research section above. We don’t exempt ourselves from the same standards we apply to the broader field. When our RSO guide makes specific research claims, you can trace them back to peer-reviewed sources with evidence strength clearly labeled.

Practical takeaways for Fiji users:

• CBD and delta-9 THC are the most evidence-developed actives in our formula
• Delta-8 THC is not trivial — it’s psychoactive with less robust safety characterization than delta-9
• THCa meaningfully changes with processing (critical in Fiji’s warm climate)
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD/THC
• Terpene claims should be careful — they’re biologically plausible but not clinically proven

We present this because you deserve the same rigor whether you’re in Texas or the Pacific Islands.

Condition-Specific Recommendations for Fiji’s Unique Needs

For Fiji’s agricultural and tourism workers with chronic pain:
Start with 0.3mL raw sublingual oil during work hours (no impairment). Add 0.5mL decarboxylated oil at night for stronger relief plus CBN for sleep. Use vape for breakthrough pain during physically demanding days.

For Fiji’s veterans and trauma survivors with PTSD:
Daytime: 0.3mL raw sublingual (CBD + CBG for anxiety without impairment). Nighttime: 1.0mL sublingual decarbed or vape for sleep architecture support. The vape form is particularly useful for acute anxiety episodes.

For Fiji’s cancer patients navigating treatment:
Use 0.5-1.0mL sublingual 1 hour before chemo. For breakthrough nausea, 2-3 vape puffs provide relief in 1-2 minutes. Nighttime: 1.0-2.0mL delivers 25-50mg CBN for sleep during difficult treatment courses. Always coordinate with your oncology team — RSO complements medical care, never replaces it.

For Fiji’s elders dealing with arthritis and inflammation:
Raw sublingual oil provides anti-inflammatory benefits (THCa COX-2 inhibition [12], caryophyllene CB2 agonism [24]) without cognitive impairment. The multi-pathway approach addresses inflammation more comprehensively than single cannabinoids.

Final Thoughts for Our Fiji Community

From the Texas-Mexico border where Colin grew up to the islands of Fiji where you’re reading this now, the thread connecting us is simple: people deserve honest options when conventional medicine falls short. Whether you’re in Suva dealing with chronic pain from years of resort work, in Nadi navigating cancer treatment, or in a village on Vanua Levu seeking sleep relief that doesn’t come with pharmaceutical side effects — you deserve education, not hype.

Our commitment to Fiji:

• Legal, Farm Bill-compliant products that can ship to your islands
• Complete formula transparency so you know exactly what you’re getting
• Evidence-based education so you can make informed decisions
• Patient-controlled potency so you decide what works for your life in Fiji
• Community-first values that prioritize people over profit

The same philosophy that led us to give away $35,000 in product to help Houston get vaccinated during COVID is what leads us to publish our formulas for Fiji families who need to make their own medicine. The same principle that made us proactively remove products when laws changed overnight is what makes us tell you honestly what the science says and doesn’t say.

Is RSO right for you? We don’t know. But we promise to give you the best possible version of the information so you can give it a fair shot and decide for yourself.

Vinaka vakalevu (thank you very much) for reading. We’re here to help.

Contact Information:

• Phone: +1 (832) 416-2816
• Email: [email protected]
• Website: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
• Instagram: @oilwellcbd
• Business Hours: Mon-Thu 10AM-7PM, Fri-Sat 10AM-10PM, Sun 10AM-4PM (CST, UTC-6)

Physical Location: 810 Richmond Ave, Houston, TX 77006, USA (Montrose neighborhood)

Fiji Customer Support: When contacting us from Fiji, please note your location so we can provide accurate shipping estimates and customs guidance.

Legal Notice: All Fiji customers are responsible for verifying local laws regarding hemp-derived cannabinoid products. OilWell Cannabis assumes no legal responsibility for customs seizures or legal issues arising from importation. Products are sold as hemp-derived wellness products, not as medicines. The 0.3% delta-9 THC compliance is based on U.S. federal law; Fiji’s regulations may differ. Please consult Fiji’s customs authority before ordering.

---